查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566961

抗菌缝线市场：按类型、最终用户划分：2024-2033 年全球机会分析与产业预测

Antimicrobial Suture Market By Type (Absorbable, Non absorbable) , By End User (Hospitals, Clinics, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

抗菌缝线市场

2023年抗菌缝线市场价值为2.979亿美元，预计2024年至2033年复合年增长率为3.7%，到2033年将达到4.301亿美元。

抗菌缝合线是渗透对细菌有毒的化合物的医用缝合线。涂在伤口上可防止细菌生长，减少感染机会。抗菌缝合线所含化学物质的作用机转是抑制细菌的细胞机转。缝合线用于各种外科手术中的创伤治疗，例如普通外科、心血管外科和整形外科外科。对于感染风险高的患者、免疫系统受损的患者以及接受长时间外科手术的患者来说，缝合至关重要。

人们对伤口和手术部位感染风险的认识不断提高，正在推动抗菌缝线的采用，从而推动市场成长。此外，由于慢性病盛行率上升、人口快速老化以及医疗设施的迅速增加，外科手术的频率也在增加。这些因素推动了对抗菌缝线的需求。目前，随着奈米工程增强抗菌性能，在缝合线製造的应用越来越受到关注。该技术也已用于设计生物分解性的缝合线。

然而，与传统缝合线相比，抗菌缝合线的成本较高，限制了其采用，特别是在低预算的医疗机构中。此外，一些医疗保健专业人员更喜欢传统抗菌缝线而不是先进的抗菌缝线，因为他们更熟悉它们，这阻碍了市场开拓。相反，具有增强性能的创新智慧缝合线的开拓预计将为市场带来新的成长机会。麻省理工学院的工程师设计了一种智慧缝合线，既能保护组织，又能在检测到发炎时释放药物。这种缝线取自动物组织，包裹着水凝胶，其中包含药物、细胞和感测器，并在需要时释放治疗分子。

按部门审查

抗菌缝线市场按类型、最终用户和地区细分。按类型划分，市场分为可吸收市场和不可吸收市场。依最终使用者分为医院、诊所和其他。从区域来看，分析涵盖北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

按类型划分，预计到 2033 年吸收剂领域将成为最大股东。

从最终用户来看，医院细分市场将在 2023 年占据市场主导地位。

按地区划分，北美地区 2023 年收益最高。

可以使用此报告进行客製化（需要额外费用和时间表）

  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章抗菌缝线市场：依类型

  • 市场概况
  • 吸水性
  • 不可吸收

第五章抗菌缝线市场：依最终用户分类

  • 市场概况
  • 医院
  • 诊所
  • 其他的

第六章抗菌缝线市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国抗菌缝线市场
    • 加拿大抗菌缝线市场
    • 墨西哥抗菌缝线市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国抗菌缝线市场
    • 德国抗菌缝线市场
    • 义大利抗菌缝线市场
    • 西班牙抗菌缝线市场
    • 英国抗菌缝线市场
    • 其他欧洲抗菌缝合线市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国抗菌缝线市场
    • 日本抗菌缝线市场
    • 印度抗菌缝线市场
    • 韩国抗菌缝线市场
    • 澳洲抗菌缝线市场
    • 其他亚太地区抗菌缝合线市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西抗菌缝线市场
    • 南非抗菌缝线市场
    • 沙乌地阿拉伯抗菌缝线市场
    • 其他拉丁美洲/中东/非洲抗菌缝线市场

第七章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第八章 公司简介

  • WL Gore And Associates
  • Medtronic Inc.,
  • Johnson And Johnson
  • Sutures India Pvt Ltd.
  • Lotus Surgicals
  • B. Braun Melsungen AG
  • Smith And Nephew Plc
  • Boston Scientific Corporation
  • Demetech Corporation
  • Conmed Corporation
简介目录
Product Code: A324365

Antimicrobial Suture Market

The antimicrobial suture market was valued at $297.9 million in 2023 and is projected to reach $430.1 million by 2033, growing at a CAGR of 3.7% from 2024 to 2033.

An antimicrobial suture is a medical stitch macerated with chemical compounds which are toxic to bacteria. It is applied on wounds to prevent the growth of bacteria and reduce the chances of infection. The action mechanism of the chemical compound present in antimicrobial sutures involves interrupting the cell mechanisms of bacteria. Different surgical procedures such as general surgeries, cardiovascular surgeries, and orthopedic surgeries involve the application of sutures for wound healing. The sutures are essential for patients with high risk of infection, with compromised immune systems, or those undergoing lengthy surgical procedures.

Increase in awareness about the risk of infection over wounds or surgical sites is enhancing the adoption of antimicrobial sutures, thereby driving the growth of the market. In addition, the frequency of surgical procedures is increasing due to rise in prevalence of chronic diseases, exponential growth of aging population, and upsurge in the availability of medical facilities. These factors are boosting the demand for antimicrobial sutures. Currently, the usage of nanoengineering in the production of sutures is acquiring traction as the technique enhances their antimicrobial properties. The technique is further being utilized to design biodegradable sutures.

However, the higher cost of antimicrobial sutures as compared to the conventional stitches restricts their adoption, particularly in the healthcare settings with low budgets. In addition, several healthcare providers prefer conventional sutures over the advanced antimicrobial sutures due to the familiarity with its application, hence restraining the development of the market. On the contrary, the development of innovative smart sutures with enhanced attributes is anticipated to present novel growth opportunities for the market. Engineers from the Massachusetts Institute of Technology have designed a smart suture which releases drugs upon the detection of inflammation, along with holding the tissue in place. Derived from animal tissues, the suture encloses hydrogel integrated with drugs, cells, or sensors, which release the therapeutic molecules when necessary.

Segment Review

The antimicrobial suture market is segmented into type, end user, and region. On the basis of type, the market is bifurcated into absorbable and non-absorbable. As per end user, it is divided into hospitals, clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the absorbable segment is expected to be the highest shareholder by 2033.

As per end user, the hospital segment dominated the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global antimicrobial suture market include W.L. Gore & Associates, Medtronic Inc., Johnson and Johnson, Sutures India Pvt Ltd., Lotus Surgicals, B. Braun Melsungen AG, Smith & Nephew plc, Boston Scientific Corporation, Demetech Corporation, and Conmed Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast

Key Market Segments

By Type

  • Absorbable
  • Non absorbable

By End User

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • W.L. Gore & Associates
    • Medtronic Inc.,
    • Johnson and Johnson
    • Sutures India Pvt Ltd.
    • Lotus Surgicals
    • B. Braun Melsungen AG
    • Smith & Nephew plc
    • Boston Scientific Corporation
    • Demetech Corporation
    • Conmed Corporation

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ANTIMICROBIAL SUTURE MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Absorbable
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Non Absorbable
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ANTIMICROBIAL SUTURE MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Clinics
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Others
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ANTIMICROBIAL SUTURE MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Type
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Antimicrobial Suture Market
      • 6.2.5.1. Market Size and Forecast, By Type
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Antimicrobial Suture Market
      • 6.2.6.1. Market Size and Forecast, By Type
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Antimicrobial Suture Market
      • 6.2.7.1. Market Size and Forecast, By Type
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Type
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. France Antimicrobial Suture Market
      • 6.3.5.1. Market Size and Forecast, By Type
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. Germany Antimicrobial Suture Market
      • 6.3.6.1. Market Size and Forecast, By Type
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. Italy Antimicrobial Suture Market
      • 6.3.7.1. Market Size and Forecast, By Type
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Spain Antimicrobial Suture Market
      • 6.3.8.1. Market Size and Forecast, By Type
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. UK Antimicrobial Suture Market
      • 6.3.9.1. Market Size and Forecast, By Type
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Antimicrobial Suture Market
      • 6.3.10.1. Market Size and Forecast, By Type
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Type
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. China Antimicrobial Suture Market
      • 6.4.5.1. Market Size and Forecast, By Type
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. Japan Antimicrobial Suture Market
      • 6.4.6.1. Market Size and Forecast, By Type
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. India Antimicrobial Suture Market
      • 6.4.7.1. Market Size and Forecast, By Type
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. South Korea Antimicrobial Suture Market
      • 6.4.8.1. Market Size and Forecast, By Type
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. Australia Antimicrobial Suture Market
      • 6.4.9.1. Market Size and Forecast, By Type
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Antimicrobial Suture Market
      • 6.4.10.1. Market Size and Forecast, By Type
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Type
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Antimicrobial Suture Market
      • 6.5.5.1. Market Size and Forecast, By Type
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. South Africa Antimicrobial Suture Market
      • 6.5.6.1. Market Size and Forecast, By Type
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. Saudi Arabia Antimicrobial Suture Market
      • 6.5.7.1. Market Size and Forecast, By Type
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Antimicrobial Suture Market
      • 6.5.8.1. Market Size and Forecast, By Type
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. W.L. Gore And Associates
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Medtronic Inc.,
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Johnson And Johnson
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Sutures India Pvt Ltd.
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Lotus Surgicals
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. B. Braun Melsungen AG
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Smith And Nephew Plc
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Boston Scientific Corporation
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Demetech Corporation
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Conmed Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments